Diagnostic challenge of systemic amyloidosis mimicking EGFR-TKI toxicity in lung adenocarcinoma: a case report
When evaluating new symptoms in patients on targeted therapies, clinicians should not assume drug toxicity as the sole cause. A high index of suspicion for underlying systemic diseases, such as amyloidosis, is essential. Timely recognition and accurate diagnosis are critical to ensure appropriate and effective patient care.
Authors
- Jooeun Lee (ORCID: https://orcid.org/0000-0002-2495-1439)
- Min‐Kyung Yeo (ORCID: https://orcid.org/0000-0001-8873-0021)
- H. D. Kang
- Hyun Yi Kim
- So-yun Kim
- Chaeuk Chung
Institutions
- Chungnam National University (KR)
- Chungnam National University Hospital (KR)
Publication Details
- Journal
- Translational Lung Cancer Research
- Published
- 2025-12-01
- DOI
- https://doi.org/10.21037/tlcr-2025-913
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00